Brief: Compass Therapeutics Announces Pricing Of Upsized $120 Million Public Offering
13/08/2025 03:28
Aug 12 (Reuters) - Compass Therapeutics Inc. CMPX.O: COMPASS THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $120 MILLION PUBLIC OFFERING COMPASS THERAPEUTICS INC. - PRICES PUBLIC OFFERING AT $3.00 PER SHARE Source text: ID:nGNXb7Mt8l Further company coverage: CMPX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Compass Therapeutics
See all newsBrief: Compass Announces Inducement Grants Under Nasdaq Listing Rule
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
U.S. STOCKS ON THE MOVE-Vicor, Thor Industries, Lennar
Brief: Compass Therapeutics Provides Regulatory Update On Tovecimig In Biliary Tract Cancer Following FDA Feedback